Alzheimer's Disease
Neurology
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2025
2026
EisaiLecanemab treatment group
Clinical Trials (1)
Total enrollment: 120 patients across 1 trials
The Clinical Study of Synaptic Plasticity-based Lencanumab for the Treatment of Early Alzheimer's Disease
Start: Mar 2025Est. completion: Dec 2026120 patients
N/ARecruiting
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
12h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
12h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
13h ago
Director of Finance
CoMind
London, UK
13h ago
Electronics Engineering Manager
CoMind
London, UK
13h ago
Director of Information Technology
Zavation Medical Products
13h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 120 patients
1 companies competing in this space